Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological erection program using prostaglandin E1.

G S Gerber1, L A Levine

  • 1Section of Urology, University of Chicago, Illinois.

The Journal of Urology
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical outcomes from limiting the use of nonabsorbable suture in tunica albuginea plication for Peyronie's disease.

International journal of impotence research·2017
Same author

Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database.

Prostate cancer and prostatic diseases·2014
Same author

Review of non-surgical treatment options for Peyronie's disease.

International journal of impotence research·2011
Same author

Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy.

International journal of impotence research·2008
Same author

Establishing a standardized evaluation of the man with Peyronie's disease.

International journal of impotence research·2003
Same author

Review of current nonsurgical management of Peyronie's disease.

International journal of impotence research·2003
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Prostaglandin E1 injections effectively treat impotence in most men, with few serious side effects. Penile pain is the most common issue, but overall, it

Area of Science:

  • Urology
  • Andrology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) affects a significant number of men.
  • Pharmacological interventions are a key treatment modality for ED.

Purpose of the Study:

  • To evaluate the safety and efficacy of intracavernous prostaglandin E1 injections for treating impotence.
  • To assess patient adherence and adverse effects associated with prostaglandin E1 therapy.

Main Methods:

  • A cohort of 72 impotent patients participated in a pharmacological erection program.
  • Patients received prostaglandin E1 via intracavernous injections.
  • Data collected on drug usage, adherence, efficacy, and adverse events.

Main Results:

Related Experiment Videos

  • 49% of patients regularly used prostaglandin E1, with a median usage duration of 7 months.
  • 11% of patients were unable to achieve an adequate erection.
  • Penile pain was the most frequent adverse effect; 17% discontinued due to severe pain.

    • Conclusions:

    • Intracavernous prostaglandin E1 injections demonstrate a favorable safety profile.
    • The treatment is effective for the majority of men with impotence.
    • Patient adherence and pain management are important considerations for successful therapy.